Net shares · 365d
-21.8K
0 buy · 21.8K sell
Net value · 365d
-$786.2K
$0 in · $786.2K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
2
0 buy · 21.8K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
VCYT Other·F
Chief Scientific & Med Officer · 10b5-1
$178.3K
3.7K sh · $47.80
Own -2%
-
VCYT Grant·A
Chief Scientific & Med Officer
$0
36.2K sh · 2 lots
Own +33%
-
VCYT Other·F
Chief Scientific & Med Officer · 10b5-1
$217.3K
6.0K sh · $36.01
Own -4%
-
VCYT Sell·S
Chief Scientific & Med Officer · 10b5-1
$485.4K
13.4K sh · $36.16
Own -10%
-
VCYT Grant·A
Chief Scientific & Med Officer
$0
71.8K sh
Own +80%
-
VCYT Other·F
Chief Scientific & Med Officer
$948.8K
24.5K sh · $38.75
Own -15%
-
VCYT Other·F
Chief Scientific & Med Officer
$136.4K
3.0K sh · $46.16
Own -3%
-
VCYT Sell·S
Chief Scientific & Med Officer · 10b5-1
$300.7K
8.3K sh · $36.02
Own -8%
-
VCYT Other·F
Chief Scientific & Med Officer
$89.0K
3.0K sh · $30.11
Own -3%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 2, 2026 | VCYT | Other F | 3.7K | $178.3K |
| Mar 6, 2026 | VCYT | Grant A | 36.2K2 lots | $0 |
| Mar 2, 2026 | VCYT | Other F | 6.0K | $217.3K |
| Mar 2, 2026 | VCYT | Sell S | 13.4K | $485.4K |
| Feb 26, 2026 | VCYT | Grant A | 71.8K | $0 |
| Feb 26, 2026 | VCYT | Other F | 24.5K | $948.8K |
| Dec 2, 2025 | VCYT | Other F | 3.0K | $136.4K |
| Oct 6, 2025 | VCYT | Sell S | 8.3K | $300.7K |
| Sep 2, 2025 | VCYT | Other F | 3.0K | $89.0K |
Buy Sell Non-market (grant · exercise · gift)
About Febbo Phillip G.
This profile aggregates every SEC Form 4 insider transaction reported by Febbo Phillip G. across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.